Company overview
Basic information
Company name
SMILTYNINIO ŠLAMUČIO, UAB
Company code
134715966
VAT code
LT347159610
Registered address
Kaunas, Savanorių pr. 177, LT-50177
Registration date
1996-04-24
Company age: 30 y. 5 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
Uždaroji akcinė bendrovė "SMILTYNINIO ŠLAMUČIO" vaistinė
Company code: 134715966
Address: Kaunas, Savanorių pr. 177, LT-50177
VAT code: LT347159610
Download a detailed company report
Make confident decisions with all the information about SMILTYNINIO ŠLAMUČIO, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
SMILTYNINIO ŠLAMUCIO, UAB (company code 134715966) is an operational private limited liability company registered on 24 April 1996. It is a micro-sized private company in the sector of national private non-financial companies and is classified as private property, meaning that Lithuanian natural and legal persons own more than 50% of its authorised capital and there is no foreign investor capital. Governance is described as CEO only. The company is based in Kaunas, Savanoriu pr. 177, Kauno m. sav., Kauno apskr.
Its main activity is EVRK code G.47.73.00, retail sale of pharmaceutical products. The share capital is EUR 24.2K. In 2025, the company generated revenue of EUR 174.6K, down 42.9% year on year and 48.4% over two years. Net result for the year was a loss of EUR 12.1K, compared with profits in 2023 and 2024, and the profit margin stood at -6.9%. Equity at the end of 2025 was EUR 12.4K, with total assets of EUR 19.0K and liabilities of EUR 6.7K.
The company had 2 average employees in 2023, 2024 and 2025, and 2 average employees so far in 2026.
Its main activity is EVRK code G.47.73.00, retail sale of pharmaceutical products. The share capital is EUR 24.2K. In 2025, the company generated revenue of EUR 174.6K, down 42.9% year on year and 48.4% over two years. Net result for the year was a loss of EUR 12.1K, compared with profits in 2023 and 2024, and the profit margin stood at -6.9%. Equity at the end of 2025 was EUR 12.4K, with total assets of EUR 19.0K and liabilities of EUR 6.7K.
The company had 2 average employees in 2023, 2024 and 2025, and 2 average employees so far in 2026.